Research library
Cognitive/peptide

Semax

Canonical identity: Semax

Also indexed as: Met-Glu-His-Phe-Pro-Gly-Pro

A synthetic ACTH-fragment analog with region-specific clinical and preclinical literature.

Evidence level

Human research, limited or context-specific

Verified against the linked source set on 2026-08-20.

What it is

Semax is a synthetic peptide analog studied in neuroprotection, stress-response, and cognitive research, particularly in Russian-language clinical contexts.

Mechanism and research questions

  • Studies have proposed effects on neurotrophic and stress-response signaling.
  • The exact mechanism and generalizability of the clinical literature remain limited.

Human evidence

Human studies exist in specific contexts; they do not establish a general cognitive-enhancement claim or approval in all jurisdictions.

Preclinical / mechanistic evidence

Animal and cellular work examines neuroprotection and stress-related endpoints.

Evidence summary

There is published research, but evidence quality, jurisdiction, formulation, and indication vary substantially.

Limits and interpretation

  • Do not generalize region-specific studies to all populations.
  • Exact formulation and quality controls matter.
  • No medical-use protocol is provided.

Regulatory and identity note

Research-use peptide; regulatory status is jurisdiction-specific.

Research summaries reflect primary literature, patent landscapes, and regulatory status reports at the time of review. They do not constitute therapeutic advice, endorsement, or claims regarding unauthorized preparations.